Rare variants in IFFO1, DTNB and NLRC3 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation
View ORCID ProfileAlexander Neumann, View ORCID ProfileFahri Küçükali, View ORCID ProfileIsabelle Bos, View ORCID ProfileStephanie J.B. Vos, View ORCID ProfileSebastiaan Engelborghs, View ORCID ProfileTim De Pooter, Geert Joris, View ORCID ProfilePeter De Rijk, Ellen De Roeck, View ORCID ProfileMagda Tsolaki, View ORCID ProfileFrans Verhey, Pablo Martinez-Lage, View ORCID ProfileMikel Tainta, View ORCID ProfileGiovanni Frisoni, Oliver Blin, Jill Richardson, Régis Bordet, View ORCID ProfilePhilip Scheltens, View ORCID ProfileJulius Popp, Gwendoline Peyratout, Peter Johannsen, Lutz Frölich, View ORCID ProfileRik Vandenberghe, View ORCID ProfileYvonne Freund-Levi, View ORCID ProfileJohannes Streffer, View ORCID ProfileSimon Lovestone, View ORCID ProfileCristina Legido-Quigley, View ORCID ProfileMara ten Kate, View ORCID ProfileFrederik Barkhof, View ORCID ProfileMojca Strazisar, View ORCID ProfileHenrik Zetterberg, View ORCID ProfileLars Bertram, View ORCID ProfilePieter Jelle Visser, View ORCID ProfileChristine van Broeckhoven, View ORCID ProfileKristel Sleegers, EMIF-AD study group, Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2021.07.10.21260177
Alexander Neumann
1Complex Genetics of Alzheimer’s Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
PhDFahri Küçükali
1Complex Genetics of Alzheimer’s Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
MscIsabelle Bos
3Netherlands Institute for Health Services Research, Utrecht, Netherlands
PhDStephanie J.B. Vos
4Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands
PhDSebastiaan Engelborghs
5Department of Neurology and Memory Clinic, Universitair Ziekenhuis Brussel (UZ Brussel) and Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
PhDTim De Pooter
6Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
BScGeert Joris
6Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
BScPeter De Rijk
6Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
PhDEllen De Roeck
7Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
PhDMagda Tsolaki
81st Department of Neurology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Makedonia, Thessaloniki, Greece
MD, PhDFrans Verhey
4Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands
9Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands
10School for Mental Health and Neuroscience,, Maastricht University, Maastricht, Netherlands
PhDPablo Martinez-Lage
11Center for Research and Advanced Therapies, CITA—Alzheimer Foundation, San Sebastian, Spain
MDMikel Tainta
11Center for Research and Advanced Therapies, CITA—Alzheimer Foundation, San Sebastian, Spain
MDGiovanni Frisoni
12Department of Psychiatry, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland
13RCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
PhDOliver Blin
14Clinical Pharmacology & Pharmacovigilance Department, Marseille University Hospital, Marseille, France
MD, PhDJill Richardson
15Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevanage, United Kingdom
PhDRégis Bordet
16Neuroscience & Cognition, CHU de Lille, University of Lille, Inserm, France
PhDPhilip Scheltens
17Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands
MDJulius Popp
18Department of Geriatric Psychiatry, University Hospital of Psychiatry Zürich, Zürich, Switzerland
19Old Age Psychiatry, Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland
MDGwendoline Peyratout
20Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland
PhDPeter Johannsen
21Clinical Drug Development, Novo Nordisk, Copenhagen, Denmark
MD, PhDLutz Frölich
22Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
MD, PhDRik Vandenberghe
23Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium
PhDYvonne Freund-Levi
24Center for Alzheimer Research, Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society Karolinska Institute Stockholm Sweden, Stockholm, Sweden
25School of Medical Sciences Örebro, University Örebro, Örebro, Sweden
PhDJohannes Streffer
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
MD, PhDSimon Lovestone
26Department of Psychiatry, University of Oxford, Oxford, United Kingdom
27Janssen Medical Ltd, United Kingdom
PhDCristina Legido-Quigley
28Steno Diabetes Center, Copenhagen, Denmark
29Institute of Pharmaceutical Sciences, King’s College London, London, United Kingdom
PhDMara ten Kate
17Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands
30Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands
PhDFrederik Barkhof
30Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands
31Institutes of Neurology and Healthcare Engineering, University College London, London, United Kingdom
MD, PhDMojca Strazisar
6Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
PhDHenrik Zetterberg
32Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden
33Department of Molecular Neuroscience,, UCL Institute of Neurology, London, United Kingdom
34Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
35UK Dementia Research Institute, University College London, London, United Kingdom
36Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China
MD, PhDLars Bertram
37Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany
38Centre for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway
MDPieter Jelle Visser
4Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands
17Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands
MD, PhDChristine van Broeckhoven
39Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
PhDKristel Sleegers
1Complex Genetics of Alzheimer’s Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
MD, PhD
Article usage
Posted July 14, 2021.
Rare variants in IFFO1, DTNB and NLRC3 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation
Alexander Neumann, Fahri Küçükali, Isabelle Bos, Stephanie J.B. Vos, Sebastiaan Engelborghs, Tim De Pooter, Geert Joris, Peter De Rijk, Ellen De Roeck, Magda Tsolaki, Frans Verhey, Pablo Martinez-Lage, Mikel Tainta, Giovanni Frisoni, Oliver Blin, Jill Richardson, Régis Bordet, Philip Scheltens, Julius Popp, Gwendoline Peyratout, Peter Johannsen, Lutz Frölich, Rik Vandenberghe, Yvonne Freund-Levi, Johannes Streffer, Simon Lovestone, Cristina Legido-Quigley, Mara ten Kate, Frederik Barkhof, Mojca Strazisar, Henrik Zetterberg, Lars Bertram, Pieter Jelle Visser, Christine van Broeckhoven, Kristel Sleegers, EMIF-AD study group, Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2021.07.10.21260177; doi: https://doi.org/10.1101/2021.07.10.21260177
Rare variants in IFFO1, DTNB and NLRC3 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation
Alexander Neumann, Fahri Küçükali, Isabelle Bos, Stephanie J.B. Vos, Sebastiaan Engelborghs, Tim De Pooter, Geert Joris, Peter De Rijk, Ellen De Roeck, Magda Tsolaki, Frans Verhey, Pablo Martinez-Lage, Mikel Tainta, Giovanni Frisoni, Oliver Blin, Jill Richardson, Régis Bordet, Philip Scheltens, Julius Popp, Gwendoline Peyratout, Peter Johannsen, Lutz Frölich, Rik Vandenberghe, Yvonne Freund-Levi, Johannes Streffer, Simon Lovestone, Cristina Legido-Quigley, Mara ten Kate, Frederik Barkhof, Mojca Strazisar, Henrik Zetterberg, Lars Bertram, Pieter Jelle Visser, Christine van Broeckhoven, Kristel Sleegers, EMIF-AD study group, Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2021.07.10.21260177; doi: https://doi.org/10.1101/2021.07.10.21260177
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)